217 related articles for article (PubMed ID: 35409038)
21. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
22. Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer.
Wang W; Wu Q; Mohyeddin A; Liu Y; Liu Z; Ge J; Zhang B; Shi G; Wang W; Wu D; Wang F
Comput Math Methods Med; 2022; 2022():5500416. PubMed ID: 36245843
[TBL] [Abstract][Full Text] [Related]
23. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
Zheng L; Dou X; Ma X; Qu W; Tang X
Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
[TBL] [Abstract][Full Text] [Related]
24. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
25. Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients.
Che H; Liu Y; Zhang M; Meng J; Feng X; Zhou J; Liang C
Med Sci Monit; 2019 Dec; 25():9991-10007. PubMed ID: 31876269
[TBL] [Abstract][Full Text] [Related]
26. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
27. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
28. Integrated Bioinformatics Analysis Identifies Hub Genes Associated with the Pathogenesis and Prognosis of Esophageal Squamous Cell Carcinoma.
Zhang H; Zhong J; Tu Y; Liu B; Chen Z; Luo Y; Tang Y; Xiao F; Zhong J
Biomed Res Int; 2019; 2019():2615921. PubMed ID: 31950035
[TBL] [Abstract][Full Text] [Related]
29. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
30. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.
Lu Y; Li C; Chen H; Zhong W
Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel biomarkers in prostate cancer diagnosis and prognosis.
Li W; Xu W; Sun K; Wang F; Wong TW; Kong AN
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23137. PubMed ID: 35686336
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
[TBL] [Abstract][Full Text] [Related]
33. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
[TBL] [Abstract][Full Text] [Related]
34. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
36. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
37. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
Ma Z; Wang J; Ding L; Chen Y
Medicine (Baltimore); 2020 Jul; 99(28):e21158. PubMed ID: 32664150
[TBL] [Abstract][Full Text] [Related]
39. Identification of the PCA29 gene signature as a predictor in prostate cancer.
Lee JY; Lin SY; Lin CY; Chuang YH; Huang SH; Tseng YY; Wang HJ; Yang JM
J Bioinform Comput Biol; 2019 Jun; 17(3):1940006. PubMed ID: 31288639
[TBL] [Abstract][Full Text] [Related]
40. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma.
Zhang Y; Chen Z; Chen JG; Chen XF; Gu DH; Liu ZM; Gao YD; Zheng B
FEBS Open Bio; 2021 Nov; 11(11):2988-3004. PubMed ID: 34449964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
